Authors:
McGuigan, C
Brancale, A
Barucki, H
Srinivasan, S
Jones, G
Pathirana, R
Blewett, S
Alvarez, R
Yarnold, CJ
Carangio, A
Velazquez, S
Andrei, G
Snoeck, R
De Clercq, E
Balzarini, J
Citation: C. Mcguigan et al., Fluorescent bicyclic furo pyrimidine deoxynucleoside analogs as potent andselective inhibitors of VZV and potential future drugs for the treatment of chickenpox and shingles, DRUG FUTURE, 25(11), 2000, pp. 1151-1161
Authors:
Verri, A
Focher, F
Duncombe, RJ
Basnak, I
Walker, RT
Coe, PL
De Clercq, E
Andrei, G
Snoeck, R
Balzarini, J
Spadari, S
Citation: A. Verri et al., Anti-(herpes simplex virus) activity of 4 '-thio-2 '-deoxyuridines: a biochemical investigation for viral and cellular target enzymes, BIOCHEM J, 351, 2000, pp. 319-326
Authors:
Snoeck, R
Noel, JC
Muller, C
De Clercq, E
Bossens, M
Citation: R. Snoeck et al., Cidofovir, a new approach for the treatment of cervix intraepithelial neoplasia grade III (CIN III), J MED VIROL, 60(2), 2000, pp. 205-209
Authors:
Sahli, R
Andrei, G
Estrade, C
Snoeck, R
Meylan, PRA
Citation: R. Sahli et al., A rapid phenotypic assay for detection of acyclovir-resistant varicella-zoster virus with mutations in the thymidine kinase open reading frame, ANTIM AG CH, 44(4), 2000, pp. 873-878
Authors:
Wang, J
Froeyen, M
Hendrix, C
Andrei, G
Snoeck, R
De Clercq, E
Herdewijn, P
Citation: J. Wang et al., The cyclohexene ring system as a furanose mimic: Synthesis and antiviral activity of both enantiomers of cyclohexenylguanine, J MED CHEM, 43(4), 2000, pp. 736-745
Authors:
McGuigan, C
Barucki, H
Blewett, S
Carangio, A
Erichsen, JT
Andrei, G
Snoeck, R
De Clercq, E
Balzarini, J
Citation: C. Mcguigan et al., Highly potent and selective inhibition of varicella-zoster virus by bicyclic furopyrimidine nucleosides bearing an aryl side chain, J MED CHEM, 43(26), 2000, pp. 4993-4997
Authors:
Martinez, A
Gil, C
Perez, C
Castro, A
Prieto, C
Otero, J
Andrei, G
Snoeck, R
Balzarini, J
De Clercq, E
Citation: A. Martinez et al., Nonnucleoside human cytomegalovirus inhibitors: Synthesis and antiviral evaluation of (chlorophenylmethyl)benzothiadiazine dioxide derivatives, J MED CHEM, 43(17), 2000, pp. 3267-3273
Authors:
Simonart, T
Degraef, C
Andrei, G
Mosselmans, R
Hermans, P
Van Vooren, JP
Noel, JC
Boelaert, JR
Snoeck, R
Heenen, M
Citation: T. Simonart et al., Iron chelators inhibit the growth and induce the apoptosis of Kaposi's sarcoma cells and of their putative endothelial precursors, J INVES DER, 115(5), 2000, pp. 893-900
Authors:
Andrei, G
Snoeck, R
De Clercq, E
Esnouf, R
Fiten, P
Opdenakker, G
Citation: G. Andrei et al., Resistance of herpes simplex virus type 1 against different phosphonylmethoxyalkyl derivatives of purines and pyrimidines due to specific mutations in the viral DNA polymerase gene, J GEN VIROL, 81, 2000, pp. 639-648
Authors:
Simonart, T
Andrei, G
Parent, D
Van Vooren, JP
De Clercq, E
Snoeck, R
Citation: T. Simonart et al., In vitro sensitivity of Kaposi's sarcoma cells to various chemotherapeuticagents including acyclic nucleoside phosphonates, ANTIVIR CHE, 10(3), 1999, pp. 129-134
Authors:
Van derpoorten, K
Ucar, H
Andrei, G
Snoeck, R
Balzarini, J
de Clercq, E
Poupaert, JH
Citation: K. Van Derpoorten et al., Synthesis and antiviral activity of 6-benzoyl-benzoxazolin-2-one and 6-benzoyl-benzothiazolin-2-one derivatives, ANTIVIR CHE, 10(2), 1999, pp. 87-97
Authors:
Santana, L
Teijeira, M
Uriarte, E
Teran, C
Andrei, G
Snoeck, R
Balzarini, J
De Clercq, E
Citation: L. Santana et al., Synthesis and biological evaluation of 1,2-disubstituted carbonucleosides of 6-substituted purine and 8-azapurine, NUCLEOS NUC, 18(4-5), 1999, pp. 733-734
Authors:
Martinez, A
Esteban, AI
Castro, A
Gil, C
Conde, S
Andrei, G
Snoeck, R
Balzarini, J
De Clercq, E
Citation: A. Martinez et al., Novel potential agents for human cytomegalovirus infection: Synthesis and antiviral activity evaluation of benzothiadiazine dioxide acyclonucleosides, J MED CHEM, 42(7), 1999, pp. 1145-1150
Authors:
McGuigan, C
Yarnold, CJ
Jones, G
Velazquez, S
Barucki, H
Brancale, A
Andrei, G
Snoeck, R
De Clercq, E
Balzarini, J
Citation: C. Mcguigan et al., Potent and selective inhibition of varicella-zoster virus (VZV) by nucleoside analogues with an unusual bicyclic base, J MED CHEM, 42(22), 1999, pp. 4479-4484
Authors:
Holy, A
Gunter, J
Dvorakova, H
Masojidkova, M
Andrei, G
Snoeck, R
Balzarini, J
De Clercq, E
Citation: A. Holy et al., Structure-antiviral activity relationship in the series of pyrimidine and purine N-[2-(2-phosphonomethoxy)ethyl] nucleotide analogues. 1. Derivativessubstituted at the carbon atoms of the base, J MED CHEM, 42(12), 1999, pp. 2064-2086
Citation: R. Snoeck et al., Current pharmacological approaches to the therapy of varicella zoster virus infections - A guide to treatment, DRUGS, 57(2), 1999, pp. 187-206
Authors:
Andrei, G
Snoeck, R
Piette, J
Delvenne, P
De Clercq, E
Citation: G. Andrei et al., Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines, ONCOL RES, 10(10), 1998, pp. 523-531